The stroma of the choroid plexus is one of the locations within the central nervous system (CNS) that serves as a shelter for tumor cells, allowing them to elude chemotherapy and potentially cause subsequent relapses in childhood ...
Sep 25, 2020
0
2
Scientists are ready to trial a new cancer vaccine in humans following the successful outcome of their preclinical studies.
Jul 9, 2020
2
241
Acute lymphoblastic leukemia (ALL) is the most common kind of cancer in children. T-ALL, a subtype that resembles T-lymphocytes, can be treated successfully with the drug nelarabine. The drug has not been successful, however, ...
Jun 24, 2020
0
1
Researchers at Children's Cancer Institute have discovered what could prove a new and improved way to treat the poor-prognosis blood cancer, acute myeloid leukaemia or AML.
Jun 19, 2020
0
17
New QIMR Berghofer research has identified how an early genetic change in blood and bone marrow cells paves the way for the development of some blood cancers.
Jun 15, 2020
0
80
T-cell ProLymphocytic leukemia (T-PLL) is the most aggressive of all known forms of leukemia. Although many cancer drugs are now available, therapeutic success is limited for T-PLL patients. Until now, no international studies ...
Sep 2, 2019
0
3
Researchers at the University of Oxford, in collaboration with colleagues from Hannover Medical School and Martin-Luther-University Halle-Wittenberg, have discovered the specific gene mutations that are required for the development ...
Jul 11, 2019
0
0
Institute scientists have revealed that a gene called PHF6 plays a powerful role in protecting against blood cancer. The study showed how a breakdown in the gene's function could accelerate the development of T cell acute ...
Apr 30, 2019
0
3
The most common form of childhood cancer is acute lymphoblastic leukaemia (ALL). Researchers at Lund University in Sweden, in cooperation with Karolinska Institutet, SciLifeLab and the University of Cambridge, have now carried ...
Apr 26, 2019
0
9
Patients living with a specific type of leukaemia will not have access to a new treatment after it failed to win provisional recommendation for use on the NHS in England.
Mar 8, 2019
0
1
